Kuros Biosurgery AG   Report issue

For profit Phase 1 Phase 2
Founded: Schlieren Switzerland (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2007
NCT00471939
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Kuros BioSciences BV | Kuros Biosurgery | Kuros Biosurgery AG | Kuros Biosurgery AG, Technoparkstrasse 1, CH-8005 Zurich